Protalix BioTherapeutics Inc (PLX)

[genisi]

From form 10-Q for PROTALIX BIOTHERAPEUTICS, INC.4-May-2011

We are working with Pfizer Inc., our commercialization partner, to respond to the CRL. We have already begun preparing our response to the CRL, with Pfizer's cooperation. We recently met with the FDA and received certain clarifications regarding the CRL.

http://phx.corporate-ir.net/phoenix.zhtml?c=101161&p=irol-SECText&TEXT=aHR0cDovL2lyLmludC53ZXN0bGF3YnVzaW5lc3MuY29tL2RvY3VtZW50L3YxLzAwMDA5NTAxMjMtMTEtMDQ0ODAzL3htbA%3d%3d

Meaning an FDA decision on uplyso is unlikely in 2011.